Mirae Asset Global Investments
BLUE

Mirae Asset Global Investments’s bluebird bio BLUE Stock Holding History

Mirae Asset Global Investments’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-344
Closed -$3.47K – 1601
2024
Q3 		$3.47K Buy
344
+60
+21% +$997 ﹤0.01% 1529
2024
Q2 		$5.39K Sell
284
-15,972
-98% -$320K ﹤0.01% 1490
2024
Q1 		$1.39M Buy
16,256
+4,507
+38% +$116K ﹤0.01% 1369
2023
Q4 		$324K Sell
11,749
-16,798
-59% -$1.02M ﹤0.01% 2165
2023
Q3 		$1.74M Buy
28,547
+1,523
+6% +$107K ﹤0.01% 1238
2023
Q2 		$1.77M Buy
27,024
+7,725
+40% +$565K ﹤0.01% 1274
2023
Q1 		$1.23M Buy
19,299
+3,229
+20% +$369K ﹤0.01% 1439
2022
Q4 		$2.22M Sell
16,070
-1,948
-11% -$274K 0.01% 1100
2022
Q3 		$2.28M Buy
18,018
+2,358
+15% +$267K 0.01% 1089
2022
Q2 		$1.3M Buy
15,660
+4,891
+45% +$379K ﹤0.01% 1286
2022
Q1 		$1.04M Sell
10,769
-2,307
-18% -$304K ﹤0.01% 1318
2021
Q4 		$2.61M Sell
13,076
-3,288
-20% -$776K 0.01% 1057
2021
Q3 		$4.05M Buy
16,364
+3,030
+23% +$866K 0.01% 913
2021
Q2 		$5.52M Buy
13,334
+200
+2% +$79.2K 0.02% 794
2021
Q1 		$5.13M Buy
13,134
+4,199
+47% +$2.07M 0.02% 728
2020
Q4 		$5.01M Buy
8,935
+3,429
+62% +$2.17M 0.02% 653
2020
Q3 		$3.88M Buy
5,506
+1,686
+44% +$1.31M 0.02% 603
2020
Q2 		$3.02M Buy
3,820
+2,744
+255% +$2.07M 0.02% 604
2020
Q1 		$640K Buy
1,076
+294
+38% +$287K 0.01% 954
2019
Q4 		$888K Buy
782
+328
+72% +$357K 0.01% 996
2019
Q3 		$539K Buy
454
+255
+128% +$389K ﹤0.01% 1130
2019
Q2 		$328K Buy
199
+100
+101% +$173K ﹤0.01% 1256
2019
Q1 		$202K Buy
+99
New +$174K ﹤0.01% 1272
2018
Q4 		– Sell
-440
Closed -$832K – 1264
2018
Q3 		$832K Buy
440
+161
+58% +$333K 0.01% 890
2018
Q2 		$566K Buy
279
+2
+0.7% +$4.56K 0.01% 602
2018
Q1 		$612K Sell
277
-106
-28% -$270K 0.01% 557
2017
Q4 		$883K Sell
383
-58
-13% -$118K 0.01% 500
2017
Q3 		$785K Buy
441
+5
+1% +$6.99K 0.01% 463
2017
Q2 		$593K Buy
436
+23
+6% +$27.8K 0.01% 472
2017
Q1 		$487K Buy
+413
New +$421K 0.01% 466

Other funds holding BLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Mirae Asset Global Investments's BLUE Position: Q4 2024 in Review

Mirae Asset Global Investments sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 344 shares — an estimated $3.47K sold.

Mirae Asset Global Investments first reported a position in BLUE in Q1 2017 and held it in 30 quarters. The position peaked at $5.52M in Q2 2021. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Mirae Asset Global Investments reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 344 bluebird bio shares in Q4 2024, an estimated $3.47K.
  • Mirae Asset Global Investments first reported a position in bluebird bio in Q1 2017 and held it in 30 quarters.
  • Mirae Asset Global Investments's bluebird bio position peaked at $5.52M in Q2 2021.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Mirae Asset Global Investments's 13F filing for Q4 2024, filed 27 Jan 2025.